Brainstorm Cell Therapeutics Inc.

BCLI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $2.5M $547.0K $428.0K $4.3M $3.5M $1.3M $1.9M $93.0K
Accounts Receivable — — — — — — $312.0K $427.0K
Inventory — — — — — — — —
Total Current Assets $9.6M $10.4M $16.8M $9.6M $4.4M $4.9M $2.3M $579.0K
Property, Plant & Equipment $392.0K $297.0K $271.0K $313.0K $258.0K $247.0K $314.0K $419.0K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $11.4M $10.8M $17.1M $9.9M $4.7M $5.1M $2.7M $1.1M
Liabilities
Accounts Payable $1.4M $345.0K $1.2M $1.5M $228.0K $358.0K $244.0K $307.0K
Total Current Liabilities $5.5M $864.0K $3.0M $3.1M $1.3M $1.2M $1.1M $1.4M
Long-Term Debt — — — — — — — —
Total Liabilities $5.5M $864.0K $3.0M $3.2M $2.0M $1.2M $1.3M $1.5M
Stockholders' Equity
Retained Earnings $-80.1M $-75.1M $-70.1M $-61.7M $-52.4M — — —
Total Stockholders' Equity $5.9M $9.9M $14.1M $6.7M $2.7M $4.0M $1.5M $-459.0K
← Newer Page 2 of 2 Older →